Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nyxoah SA - Ordinary Shares (NQ: NYXH )

6.030 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,467
Open 6.030
Bid (Size) 5.900 (5)
Ask (Size) 6.210 (1)
Prev. Close 6.030
Today's Range 6.030 - 6.030
52wk Range 5.550 - 12.21
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH
From Pomerantz LLP
Via GlobeNewswire

Performance

YTD
-33.30%
-33.30%
1 Month
-46.64%
-46.64%
3 Month
-41.96%
-41.96%
6 Month
-37.12%
-37.12%
1 Year
-42.46%
-42.46%

More News

Read More
Conditional Issuance of Shares
From Nyxoah
Via GlobeNewswire
Which stocks have an unusual volume on Monday?
Via Chartmill
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH
From Pomerantz LLP
Via GlobeNewswire
Nyxoah Provides Update on FDA Approvable Letter for Genio System
From Nyxoah
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH
From Pomerantz LLP
Via GlobeNewswire
NYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH
From Pomerantz LLP
Via GlobeNewswire
Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
FDA Issues Nyxoah an Approvable Letter for its Genio® System
From Nyxoah
Via GlobeNewswire
Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results
From Nyxoah
Via GlobeNewswire
Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025
From Nyxoah
Via GlobeNewswire
Earnings Scheduled For March 13, 2025
Via Benzinga
Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
From Nyxoah
Via GlobeNewswire
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East
From Nyxoah
Via GlobeNewswire
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England
From Nyxoah
Via GlobeNewswire
Information on the total number of voting rights and shares
From Nyxoah
Via GlobeNewswire
Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference
From Nyxoah
Via GlobeNewswire
Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024
From Nyxoah
Via GlobeNewswire
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Nyxoah Reports Third Quarter Financial and Operating Results
From Nyxoah
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.